Across TCGA pan-cancer cohorts, MIR32 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR32’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where MIR32 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR32 is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

BRCA, LUSC, and UCEC are the cancer types where MIR32 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR32 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	−0.428	<.001	6	view →
LUSC	Male	All	−0.281	.012	3	view →
UCEC	All	All	−0.294	.019	2	view →
COAD	Female	II,III,IV	−0.182	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR32 RNA expression & survival · all MIR32 data types